Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults

American Journal of Clinical Nutrition

Volumn 90, Issue 2, 2009, Pages 329-335

  Czernichow, Sébastien ^a,b   Vergnaud, Anne Claire ^a   Galan, Pilar ^a   Arnaud, Josiane ^c,d   Favier, Alain ^c,d   Faure, Henri ^c   Huxley, Rachel ^e   Hercberg, Serge ^a,b   Ahluwalia, Namanjeet ^f  

^a Paris 13 University ^*  (France)

^b AVICENNE HOSPITAL   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITY OF SYDNEY   (Australia)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; GLUCONATE ZINC; PLACEBO; SELENIUM; ZINC; MINERAL; VITAMIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; PATIENT COMPLIANCE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; FRANCE; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR;

ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MINERALS; ODDS RATIO; RISK FACTORS; SELENIUM; VITAMIN E; VITAMINS; ZINC;

EID: 67949094377     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.27635     Document Type: Article

References (42)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359 (Pubitemid 34251969)
3. Ahluwalia N, Drouet L, Ruidavets JB, et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2006;186:345-353
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716 (Pubitemid 35403784)
5. Benetos A, Thomas F, Pannier B, Bean K, Jego B, Guize L. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol 2008;102:188-191
6. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072 (Pubitemid 43113437)
7. Czernichow S, Bertrais S, Blacher J, et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. vascular study. Am J Hypertens 2005;18:1154-1160 (Pubitemid 41337966)
8. Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-4971
9. Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003;41:1096-1101 (Pubitemid 36548609)
10. Kontush A, de Faria EC, Chantepie S, Chapman MJ. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 2005;182:277-285 (Pubitemid 41267195)
11. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-2072 (Pubitemid 35192812)
12. Paolisso G, D'Amore A, Volpe C, et al. Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994;43:1426-1429 (Pubitemid 24353109)
13. Sargeant LA, Wareham NJ, Bingham S, et al. Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care 2000;23:726-732 (Pubitemid 30414183)
14. Harding AH, Wareham NJ, Bingham SA, et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer-Norfolk prospective study. Arch Intern Med 2008;168:1493-1499
15. Hercberg S, Czernichow S, Galan P. Vitamin C concentration and type 2 diabetes mellitus. Arch Intern Med 2009;169:634.
16. Ford ES, Mokdad AH. Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults. Prev Med 2001;32:33-39 (Pubitemid 34135416)
17. Mayer-Davis EJ, Costacou T, King I, Zaccaro DJ, Bell RA. Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: the Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 2002;25:2172-2177 (Pubitemid 41071023)
18. Knekt P, Reunanen A, Marniemi J, Leino A, Aromaa A. Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J Intern Med 1999;245:99-102. (Pubitemid 29049149)
19. Czernichow S, Bertrais S, Blacher J, et al. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI. MAX study: association with plasma antioxidant levels. J Hypertens 2005;23:2013-2018 (Pubitemid 41830396)
20. Czernichow S, Couthouis A, Bertrais S, et al. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr 2006;84:395-399 (Pubitemid 44699151)
21. Obeid O, Elfakhani M, Hlais S, et al. Plasma copper, zinc, and selenium levels and correlates with metabolic syndrome components of lebanese adults. Biol Trace Elem Res 2008;123:58-65.
22. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-2352 (Pubitemid 37059506)
23. Rock CL. Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 2007;85:277S-9S.
24. Hercberg S, Preziosi P, Briancon S, et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 1998;19:336-351 (Pubitemid 28355758)
25. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-2342 (Pubitemid 39532244)
26. Hercberg S, Bertrais S, Czernichow S, et al. Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study. Lipids 2005;40:335-342 (Pubitemid 40770943)
27. Bourgeois CF, Chartois RR, Counstans MF, George PR. Automated determination of vitamin C in foodstuffs and biological tissues. Analysis 1989;9:519-525
28. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008;46:499-505. (Pubitemid 351820355)
29. Bhatt DL. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Am J Cardiol 2008;101:4D-13D.
30. Willcox BJ, Curb JD, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol 2008;101:75D-86D.
31. Andersen LF, Jacobs DR Jr, Gross MD, Schreiner PJ, Dale WO, Lee DH. Longitudinal associations between body mass index and serum carotenoids: the CARDIA study. Br J Nutr 2006;95:358-365
32. Wallstrom P, Wirfalt E, Lahmann PH, Gulberg B, Janzon L, Berglund G. Serum concentration of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr 2001;73:777-785 (Pubitemid 32239232)
33. Liu S, Ajani U, Chae C, Hennekens C, Buring JE, Manson JE. Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 1999;282:1073-1075 (Pubitemid 29436456)
34. Hozawa A, Jacobs DR Jr, Steffes MW, Gross MD, Steffen LM, Lee DH. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006;163:929-937 (Pubitemid 43752359)
35. Lee O, Moon J, Chung Y. The relationship between serum selenium levels and lipid profiles in adult women. J Nutr Sci Vitaminol (Tokyo) 2003;49:397-404. (Pubitemid 38035145)
36. Sebekova K, Boor P, Valachovicova M, et al. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res 2006;50:858-868 (Pubitemid 44433098)
37. Frassinetti S, Bronzetti G, Caltavuturo L, Cini M, Croce CD. The role of zinc in life: a review. J Environ Pathol Toxicol Oncol 2006;25:597-610.
38. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292:1440-1446 (Pubitemid 39258336)
39. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol 2008;101:14D-9D.
40. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786 (Pubitemid 26091640)
41. Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 2002;25:1919-1927 (Pubitemid 41071045)
42. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 2003;26:3264-3272 (Pubitemid 37466885)